Research programme: metabotropic glutamate receptor modulators - AmgenAlternative Names: Compound 4; Compound 6
Latest Information Update: 06 Apr 2011
At a glance
- Originator Amgen
- Mechanism of Action Metabotropic glutamate receptor 4 modulators; Metabotropic glutamate receptor 5 modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Parkinson's disease; Schizophrenia